Your browser doesn't support javascript.
loading
A Pilot Study of Gut-Brain Signaling After Octreotide Therapy for Unintentional Weight Loss After Esophagectomy.
Murphy, Conor F; Stratford, Nicholas; Docherty, Neil G; Moran, Brendan; Elliott, Jessie A; Healy, Marie-Louise; McMorrow, Jason P; Ravi, Narayanasamy; Goldstone, Anthony P; Reynolds, John V; le Roux, Carel W.
Afiliação
  • Murphy CF; Diabetes Complications Research Centre, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin 4, Ireland.
  • Stratford N; National Oesophageal and Gastric Centre, Trinity Centre for Health Sciences, Trinity College Dublin and St. James's Hospital, Dublin, Ireland.
  • Docherty NG; Diabetes Complications Research Centre, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin 4, Ireland.
  • Moran B; Diabetes Complications Research Centre, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin 4, Ireland.
  • Elliott JA; Diabetes Complications Research Centre, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin 4, Ireland.
  • Healy ML; Diabetes Complications Research Centre, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin 4, Ireland.
  • McMorrow JP; National Oesophageal and Gastric Centre, Trinity Centre for Health Sciences, Trinity College Dublin and St. James's Hospital, Dublin, Ireland.
  • Ravi N; Department of Endocrinology, St. James's Hospital, Dublin, Ireland.
  • Goldstone AP; Department of Radiology, St. James's Hospital, Dublin, Ireland.
  • Reynolds JV; National Oesophageal and Gastric Centre, Trinity Centre for Health Sciences, Trinity College Dublin and St. James's Hospital, Dublin, Ireland.
  • le Roux CW; PsychoNeuroEndocrinology Research Group, Centre for Neuropsychopharmacology, Division of Psychiatry, and Computational, Cognitive, and Clinical Neuroimaging Laboratory, Department of Brain Sciences, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, UK.
J Clin Endocrinol Metab ; 106(1): e204-e216, 2021 01 01.
Article em En | MEDLINE | ID: mdl-33000149
ABSTRACT

BACKGROUND:

Recurrence-free patients after esophageal cancer surgery face long-term nutritional consequences, occurring in the context of an exaggerated postprandial gut hormone response. Acute gut hormone suppression influences brain reward signaling and eating behavior. This study aimed to suppress gut hormone secretion and characterize reward responses and eating behavior among postesophagectomy patients with unintentional weight loss.

METHODS:

This pilot study prospectively studied postoperative patients with 10% or greater body weight loss (BWL) beyond 1 year who were candidates for clinical treatment with long-acting octreotide (LAR). Before and after 4 weeks of treatment, gut hormone secretion, food cue reactivity (functional magnetic resonance imaging), eating motivation (progressive ratio task), ad libitum food intake, body composition, and symptom burden were assessed.

RESULTS:

Eight patients (7 male, age mean ±â€…SD 62.8 ±â€…9.4 years, postoperative BWL 15.5 ±â€…5.8%) participated. Octreotide LAR did not significantly suppress total postprandial plasma glucagon-like peptide-1 response at 4 weeks (P = .08). Postprandial symptom burden improved after treatment (Sigstad score median [range] 12 [2-28] vs 8 [3-18], P = .04) but weight remained stable (pre 68.6 ±â€…12.8 kg vs post 69.2 ±â€…13.4 kg, P = .13). There was no significant change in brain reward system responses, during evaluation of high-energy or low-energy food pictures, nor their appeal rating. Moreover, treatment did not alter motivation to eat (P = .41) nor ad libitum food intake(P = .46).

CONCLUSION:

The protocol used made it feasible to characterize the gut-brain axis and eating behavior in this cohort. Inadequate suppression of gut hormone responses 4 weeks after octreotide LAR administration may explain the lack of gut-brain pathway alterations. A higher dose or shorter interdose interval may be required to optimize the intervention.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Octreotida / Esofagectomia / Síndrome de Emaciação Tipo de estudo: Etiology_studies / Guideline Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Endocrinol Metab Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Irlanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Octreotida / Esofagectomia / Síndrome de Emaciação Tipo de estudo: Etiology_studies / Guideline Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Endocrinol Metab Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Irlanda